All-trans retinoic acid plus high-dose dexamethasone as first-line treatment for patients with newly diagnosed immune thrombocytopenia: a multicentre, open-label, randomised, controlled, phase 2 trial

Autor: Huang, Qiu-Sha, Liu, Yi, Wang, Jing-Bo, Peng, Jun, Hou, Ming, Liu, Hui, Feng, Ru, Wang, Jing-Wen, Xu, Lan-Ping, Wang, Yang, Huang, Xiao-Jun, Zhang, Xiao-Hui *
Zdroj: In The Lancet Haematology October 2021 8(10):e688-e699
Databáze: ScienceDirect